India Glycols Limited
Financial trend (76/100) does the heavy lifting; momentum (0/100) is the drag.
Fair valueIndia Glycols Limited earns a Hold from StocksWizard, with a blended score of 51/100. We put fair value near ₹589.8; at ₹294.9 that leaves roughly 100% upside, so the stock screens undervalued by 100%. On 25.2x trailing earnings it sits pricier than the Basic Materials median of about 22.2x. The price is about 75% below its 52-week high of ₹1,203.3 and 25% above the low of ₹236.2. Financial health scores 39/100, in the grey band on the Altman Z-score, with a Piotroski F-score of 5/9. It clears 4 of 13 investability checks, with durability 45, valuation 45 and momentum 0 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹471.84. Low-confidence estimate — limited data.
1-year price
EOD · 2026-09-1452-week range
-75.49% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Hold51Piotroski F-score 5/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 11.3%
- Fail: Low debt (D/E < 0.5): 0.58x
- Fail: Positive free cash flow
- Pass: Revenue growth > 10%: 13%
- Pass: Earnings growing: 32%
- Fail: Net margin ≥ 10%: 7.0%
- Fail: Current ratio > 1.5: 0.74
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Fail: Altman Z in safe zone: Z 2.56
- Fail: Piotroski ≥ 7: 5/9
Quarterly results
Annual financials
Shareholding
- Promoter63.8%
- Institutions3.4%
- Public & other32.8%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Opportunities
- Earnings growing (32% YoY).
- Revenue growing (13% YoY).
- Well off its 52-week high — possible mean-reversion.
- Trades ~100% below our estimated fair value.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
About India Glycols Limited
India Glycols Limited manufactures industrial chemicals through three operating segments: Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma. The company produces mono, di, and tri ethylene glycols, glycol ethers and acetates, brake fluids, bio-polymers including guar and natural gums, biofuels, and specialty chemicals such as plasticizers and oilfield chemicals.
India Glycols Limited — frequently asked questions
Is India Glycols Limited a buy, hold or sell?
StocksWizard currently rates India Glycols Limited (INDIAGLYCO) a Hold, based on a blended score of 51/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is India Glycols Limited's fair value?
Our blended DCF and relative-valuation model estimates India Glycols Limited's fair value at about ₹589.8, versus a current price of ₹294.9 — roughly 100% upside. On that basis the stock looks undervalued by 100%.
Is India Glycols Limited financially healthy?
India Glycols Limited scores 39/100 on our financial-health model, placing it in the grey band on the Altman Z-score, with a Piotroski F-score of 5/9.
How has India Glycols Limited's share price performed?
India Glycols Limited is down 70% over three months, and last traded at ₹294.9. Past performance doesn't predict future returns.
More in Basic Materials
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.